JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M605391200 on July 7, 2006

J. Biol. Chem., Vol. 281, Issue 36, 26562-26568, September 8, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/36/26562    most recent
M605391200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okumura, K.
Right arrow Articles by Furnari, F. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okumura, K.
Right arrow Articles by Furnari, F. B.
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

PCAF Modulates PTEN Activity*{diamondsuit}

Koichi Okumura{ddagger}, Michelle Mendoza§, Robert M. Bachoo, Ronald A. DePinho||**, Webster K. Cavenee{ddagger}§{ddagger}{ddagger}§§, and Frank B. Furnari{ddagger}§§1

From the {ddagger}Ludwig Institute for Cancer Research, San Diego Branch, §Biomedical Sciences Graduate Program, {ddagger}{ddagger}Center for Molecular Genetics, §§Department of Medicine and Cancer Center, University of California at San Diego, La Jolla, California 92093-0660, the Departments of Neurology and Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9133, and the ||Department of Medical Oncology and **Departments of Genetics and Medicine, Harvard Medical School, Boston, Massachusetts 02115

The PTEN protein has a single catalytic domain possessing both lipid phosphoinositol and protein phosphatase activities. The lipid phosphoinositol phosphatase activity is essential for PTEN to block the cell cycle in the G1 phase and thereby to suppress tumor formation and progression (Cantley, L. C., and Neel, B. G. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4240-4245), although the mechanisms governing PTEN activity under normal and neoplastic growth conditions remain unclear. Here, we report that PTEN interacts physically and functionally with PCAF, a histone acetyltransferase that regulates gene transcription through interaction with p300/CBP and various sequencespecific transcription factors (Nakatani, Y. (2001) Genes Cells 6, 79-86). Expression of PCAF results in increased acetylation of lysine residues (Lys125 and Lys128) within the catalytic cleft of PTEN, a structure essential for phosphatidylinositol 3,4,5-trisphosphate specificity (Lee, J. O., Yang, H., Georgescu, M. M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., and Pavletich, N. P. (1999) Cell 99, 323-334). The acetylation of PTEN caused by PCAF expression depends on the presence of growth factors. Reduction of endogenous PCAF activity using shRNA results in a loss of PTEN acetylation in response to growth factors and restores the ability of PTEN to down-regulate phosphatidylinositol 3-kinase signaling and to induce G1 cell cycle arrest. The retention of phosphatidylinositol 3-kinase/AKT signaling and cell cycle regulatory activities of acetylationresistant PTEN K125R and K128R mutants in the presence of enforced PCAF expression suggest a causal relationship. Together, these findings indicate a mechanism of PTEN regulation that forges a link between distinct cancer-relevant pathways central to the control of growth factor signaling and gene expression.


Received for publication, June 5, 2006 , and in revised form, July 6, 2006.

* This work was supported in part by Scholar Awards for cancer research from the Kimmel Foundation and the V Foundation (to F. B. F.), Grant CA95616 from the National Cancer Institute (to W. K. C., R. M. B., F. B. F., and R. A. D.), and by a Fellow Award from the National Foundation for Cancer Research (to W. K. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{diamondsuit} This article was selected as a Paper of the Week.

1 To whom correspondence should be addressed. Tel.: 858-534-7819; Fax: 858-534-7750; E-mail: ffurnari{at}ucsd.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
T. Ikenoue, K. Inoki, B. Zhao, and K.-L. Guan
PTEN Acetylation Modulates Its Interaction with PDZ Domain
Cancer Res., September 1, 2008; 68(17): 6908 - 6912.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Roy, R. Jeffrey, and M. Tenniswood
Array-based analysis of the effects of trichostatin A and CG-1521 on cell cycle and cell death in LNCaP prostate cancer cells
Mol. Cancer Ther., July 1, 2008; 7(7): 1931 - 1939.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X.-H. Yao and B. L. G. Nyomba
Hepatic insulin resistance induced by prenatal alcohol exposure is associated with reduced PTEN and TRB3 acetylation in adult rat offspring
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1797 - R1806.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Dey, H. E. Crosswell, P. De, R. Parsons, Q. Peng, J. D. Su, and D. L. Durden
The Protein Phosphatase Activity of PTEN Regulates Src Family Kinases and Controls Glioma Migration
Cancer Res., March 15, 2008; 68(6): 1862 - 1871.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. Tamguney and D. Stokoe
New insights into PTEN
J. Cell Sci., December 1, 2007; 120(23): 4071 - 4079.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
E. D. Eliseeva, V. Valkov, M. Jung, and M. O. Jung
Characterization of novel inhibitors of histone acetyltransferases
Mol. Cancer Ther., September 1, 2007; 6(9): 2391 - 2398.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Roy and M. Tenniswood
Site-specific Acetylation of p53 Directs Selective Transcription Complex Assembly
J. Biol. Chem., February 16, 2007; 282(7): 4765 - 4771.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
D. F. Barber, M. Alvarado-Kristensson, A. Gonzalez-Garcia, R. Pulido, and A. C. Carrera
PTEN Regulation, a Novel Function for the p85 Subunit of Phosphoinositide 3-Kinase
Sci. Signal., November 21, 2006; 2006(362): pe49 - pe49.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.